This state-of-the-art research laboratory unites a select, multidisciplinary team of exceptional scientific minds around a shared purpose: to drive medical advances against some of the most challenging diseases facing ageing populations. The Centre and interim facilities represent MSD's investment in – and commitment to – highly principled and rigorous early bioscience research conducted in the most forward-looking ways.
Our London discovery research teams call on their expertise as biologists, pharmacologists and chemists to collaborate and translate fundamental discoveries, which could be groundbreaking. The UK Discovery Centre and interim facilities represent MSD's initial expansion of this cross-disciplinary model into Europe. Others are already underway at MSD Research Labs in the U.S. (South San Francisco, CA, and Cambridge, MA), all with distinct scientific charters.
...brave, pushing boundaries and pursuing avenues where others have given up. Led by renowned scientist Dr Fiona Marshall, PhD, a world-leading expert and innovator in drug discovery, the MSD UK Discovery Centre and our discovery research teams focus on the study of changes in the fundamental mechanisms of cell homeostasis and resilience in the context of ageing that lead to disease, particularly the processes which result in neurodegeneration.
In a quest to drive early research to rapidly identify and progress novel therapeutic targets for diseases, commitment will be to scientific nimbleness and fluidity, moving efficiently and with purpose into areas yielding greatest promise. Our teams combine leading drug discovery capabilities and world-class R&D with the purpose of turning breakthrough science into life-changing medicines.